$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10:35am, Thursday, 26'th Jun 2025
The heavy selling pressure might have exhausted for Hims & Hers Health (HIMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street
Hims Won't Back Down From Selling Cheap Weight-Loss Shots
09:47am, Thursday, 26'th Jun 2025
Hims & Hers Health CEO Andrew Dudum said the company will continue to sell cheap weight-loss shots despite Novo Nordisk A/S ending their distribution partnership over "deceptive marketing" practices.
HIMS SECURITIES: Lose Money on Hims & Hers Health, Inc. (NYSE:HIMS)? Contact BFA Law about the Pending Securities Fraud Investigation
08:35am, Thursday, 26'th Jun 2025
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the
Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity?
07:00am, Thursday, 26'th Jun 2025
Novo Nordisk (NVO -4.81%) severed its partnership with Hims & Hers (HIMS -3.65%), arguing that the company breached the agreement between the two.
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June
HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc.
08:57pm, Wednesday, 25'th Jun 2025
LOS ANGELES--(BUSINESS WIRE)--HIMS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Hims & Hers Health, Inc.
HIMS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Hims & Hers Health, Inc. Investors
06:45pm, Wednesday, 25'th Jun 2025
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, c
Block & Leviton LLP filed a class action lawsuit today against Hims & Hers Health Inc. (NYSE: HIMS). Investors should contact Block & Leviton by August 25.
SAN FRANCISCO , June 25, 2025 /PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares crash over 30% after Novo Nordisk announced that it ter
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
11:10am, Wednesday, 25'th Jun 2025
LOS ANGELES, June 25, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Healt
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 25'th Jun 2025
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hims & Hers: Panic Sell Or Opportunistic Buy?
04:58am, Wednesday, 25'th Jun 2025
The Hims & Hers and Novo Nordisk "long-term collaboration" has ended up in flames within a couple of months, causing steep declines in both stocks. In this report, we discuss the breakup and assess th
SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible
Berger Montague Investigates Potential Securities Class Action Against Hims & Hers Health, Inc.
05:42pm, Tuesday, 24'th Jun 2025
PHILADELPHIA , June 24, 2025 /PRNewswire/ -- Berger Montague , a nationally recognized securities litigation firm, is investigating potential claims on behalf of investors who purchased or otherwise
Kirby McInerney LLP Announces Investigation Against Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
04:49pm, Tuesday, 24'th Jun 2025
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS)
Sign In
Buy HIMS